- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- The ReproPsych Group
- CAS Newsletter
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
2013 FACE meeting
Fetal Alcohol Canadian Expertise (FACE) Satellite Meeting .
- Read more in our News Archive
Current Studies at Motherisk
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Environmental Exposures and Children's Health
Alcohol Use during Pregnancy
Control of Hypertension in Pregnancy Study
Folic Acid Before and During Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Exposures in Pregnancy: Perception of Teratogenic Risk
Lancet. 2001 Oct 13;358(9289):1237-8.
Jasper JD, Goel R, Einarson A, Gallo M, Koren G: Effects of framing on teratogenic risk perception in pregnant women.
J Clin Pharmacol. 2000 Jun;40(6):573-7.
Pole M, Einarson A, Pairaudeau N, Einarson T, Koren G: Drug labeling and risk perceptions of teratogenicity: a survey of pregnant Canadian women and their health professionals.
Reprod Toxicol. 1999 Jul-Aug;13(4):313-9.
Mazzotta P, Magee LA, Maltepe C, Lifshitz A, Navioz Y, Koren G: The perception of teratogenic risk by women with nausea and vomiting of pregnancy.
Amer J Obstet Gynecol, 160: 1190-1194, 1989.
Koren G, Bologa-Campeneau M, Long D, Henderson K, Feldman Y, Shear, N: Perception of teratogenic risk by pregnant women exposed to drugs and chemicals in early pregnancy.
Teratology 41: 657-661, 1990.
Koren G, Pastuszak A, Pellegrini E: Prevention of unnecessary pregnancy termination by counseling women on drug, chemical and radiation exposure during the first trimester
Teratology 43: 109-112, 1991.
Bentur G, Horlatch N, Koren G: Exposure to ionizing radiation during pregnancy; Perception of teratogenic risk and outcome.
Teratology 46: 567-571, 1992.
Koren G, Gladstone D, Robeson C, Robieux I: The perception of teratogenic risk of cocaine.
November 20-21, 1990, Ottawa. Canadian Public Health Association, Health & Welfare Canada and World Health Organization.
Koren G, Pastuszak A, Bologa M: Women's perception of teratogenic risk. Proceedings of the International Symposium on "Risk Estimation for Pharmaceuticals".
Can J Publ Health 82: S11-S14, 1991 No abstract available.
Koren G, Bologa M, Pastuszak, A: Women's perception of teratogenic risk.
Ann N Y Acad Sci 78: 317-324, 1993. No abstract available.
Koren G, Bologa M, Pastuszak, A: How women perceive teratogenic risk and what they do about it.
Koren G: Perception of teratogenic risk by women and their physicians. In: (G. Koren, ed) Folic acid for the prevention of neural tube defects. The Motherisk Program, 47-49, 1995.
Teratology, 40: 37-45, 1989.
Feldman Y, Koren G, Mattice D, Shear H, Pellegrini E, MacLeod SM: Determinants of recall and recall bias in studying drug and chemical exposure in pregnancy.
Reprod Toxicol. 2001 Jan;15(1):1-3. No abstract available.
Koren G: Misrepresentation and miscommunication of teratogenic risk of drugs; analysis of three highly publicized international cases